id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-1343-0001,FDA,FDA-2021-N-1343,Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Integrated Continuous Glucose Monitoring System,Rule,Final Rule,2022-02-18T05:00:00Z,2022,2,2022-02-18T05:00:00Z,,2022-02-18T14:23:19Z,2022-03504,0,0,0900006484f85796